Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsAdriano Gravina, Federica Perrone, P. Gargiulo et al.|ESMO Open|2025Cited by 8
What is the role of QTc prolongation assessment in new drugs development phase I oncology trials?Giuseppe Curigliano, Filippo de Braud, Tomasso De Pas et al.|Journal of Clinical Oncology|2006Cited by 5